Osaka, Japan

Fujio Kobayashi

This inventor holds 1 USPTO granted patent. Top assignee: Welfide Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fujio Kobayashi. Retrieved from https://idiyas.com/inventor/fujio-kobayashi-undesy0p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fujio Kobayashi: Innovator in Antibody Production Inhibitors

Introduction

Fujio Kobayashi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of inhibitors for IgE antibody production and autoimmune diseases. His innovative work has the potential to impact the treatment of various allergic and autoimmune conditions.

Latest Patents

Fujio Kobayashi holds 1 patent related to his research on IgE antibody production inhibitors. This patent represents a crucial advancement in understanding and potentially mitigating the effects of autoimmune diseases.

Career Highlights

Kobayashi is currently associated with Welfide Corporation, where he continues to push the boundaries of scientific research and innovation. His work at the company focuses on developing therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Fujio Kobayashi has collaborated with notable colleagues, including Shigeki Kuwahara and Naruyasu Komorita. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Fujio Kobayashi's contributions to the field of biotechnology, particularly in the area of antibody production inhibitors, highlight his role as an influential inventor. His ongoing work at Welfide Corporation continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…